Wang, Z.; Jin, Y.; Guo, Y.; Tan, Z.; Zhang, X.; Ye, D.; Yu, Y.; Peng, S.; Zheng, L.; Li, J.
Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid. Cancers 2021, 13, 1179.
https://doi.org/10.3390/cancers13051179
AMA Style
Wang Z, Jin Y, Guo Y, Tan Z, Zhang X, Ye D, Yu Y, Peng S, Zheng L, Li J.
Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid. Cancers. 2021; 13(5):1179.
https://doi.org/10.3390/cancers13051179
Chicago/Turabian Style
Wang, Zhiwei, Yun Jin, Yinghao Guo, Zhenhua Tan, Xiaoxiao Zhang, Dan Ye, Yuanquan Yu, Shuyou Peng, Lei Zheng, and Jiangtao Li.
2021. "Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid" Cancers 13, no. 5: 1179.
https://doi.org/10.3390/cancers13051179
APA Style
Wang, Z., Jin, Y., Guo, Y., Tan, Z., Zhang, X., Ye, D., Yu, Y., Peng, S., Zheng, L., & Li, J.
(2021). Conversion Therapy of Intrahepatic Cholangiocarcinoma Is Associated with Improved Prognosis and Verified by a Case of Patient-Derived Organoid. Cancers, 13(5), 1179.
https://doi.org/10.3390/cancers13051179